How to Calculate Wegovy Dose by Clicks: A Complete Guide to Pen Mechanics and Off-Label Dosing

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Wegovy pens are single-dose devices with no dose selector dial. Each pen delivers one fixed dose (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg) with a single click of the injection button.
• You cannot "calculate" dose by clicks because there is no variable click mechanism. The pen you receive from the pharmacy already contains your prescribed dose.
• Off-label partial dosing (drawing from a Wegovy pen into a syringe to split doses) voids sterility guarantees and is not manufacturer-approved, but some patients attempt it during shortages.
• Compounded semaglutide in vials allows true dose customization using syringe unit measurements, which is why many patients switch during titration.

Direct answer (40-60 words)

Wegovy pens do not require dose calculation by clicks. Each pen is pre-filled with a single fixed dose and delivers the entire contents in one injection when you press the button until it clicks and holds. The pen model number on the box tells you the dose: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg.

Table of contents

1. Why "calculating dose by clicks" is the wrong mental model for Wegovy
2. How Wegovy pens actually work (single-dose, single-click design)
3. Wegovy pen identification chart by dose
4. What most articles get wrong about Wegovy pen mechanics
5. Off-label partial dosing: drawing from a pen with a syringe
6. When you should NOT attempt pen-to-syringe extraction
7. Compounded semaglutide as the alternative for dose flexibility
8. Step-by-step: using a Wegovy pen correctly (one-click injection)
9. Troubleshooting: pen won't click, dose window issues, injection button stuck
10. FormBlends clinical pattern: why patients search for "dose by clicks"
11. FAQ
12. Sources

Why "calculating dose by clicks" is the wrong mental model for Wegovy

The search query "how to calculate Wegovy dose by clicks" reflects a reasonable assumption: most injectable diabetes medications (insulin pens, Trulicity, Victoza) have dose selector dials that click as you rotate them to set a dose. Patients count clicks to reach the prescribed number.

Wegovy does not work this way.

Wegovy pens are single-dose, pre-filled injectors. Each pen contains exactly one dose of semaglutide, and the entire pen is discarded after a single injection. There is no dose selector, no dial, and no variable click count. The only "click" is the injection button locking into place when the full dose has been delivered.

The confusion arises because:

1. Patients switching from insulin or other GLP-1 pens expect a dose selector mechanism.
2. Pharmacy instructions sometimes say "inject until you hear a click," which sounds like counting clicks rather than waiting for a single mechanical lock.
3. Off-label use during shortages has led some patients to draw partial doses from Wegovy pens using syringes, which does require volume calculation, but this is not the intended use.

If you're looking for dose flexibility (splitting a 1 mg pen into two 0.5 mg injections, for example), Wegovy's design does not support it. Compounded semaglutide in vials is the product class designed for dose customization.

How Wegovy pens actually work (single-dose, single-click design)

Wegovy uses the FlexTouch pen platform, the same autoinjector design as Novo Nordisk's Ozempic (also semaglutide) and Saxenda (liraglutide). The pen body contains a pre-filled syringe, a spring-loaded plunger mechanism, and a single-use needle that attaches to the tip.

Injection sequence:

1. Attach a new pen needle to the pen tip.
2. Perform a flow check (prime the pen) by dialing to the flow check symbol and pressing the button until a drop of semaglutide appears at the needle tip. This confirms the needle is attached correctly and the pen is functional.
3. Select your injection site (abdomen, thigh, or upper arm). Clean with an alcohol swab.
4. Insert the needle at a 90-degree angle into the skin.
5. Press the injection button fully. You'll hear a click as the mechanism engages.
6. Hold the button down and count to 6 seconds. The dose counter in the pen window will move to "0" and a second click will sound when delivery is complete.
7. Remove the needle from the skin, then remove the pen needle and dispose of it in a sharps container.

The "click" patients hear is the injection button locking into the fully depressed position after the spring mechanism has expelled the full dose. It is not a dose-setting click. You cannot stop halfway, and you cannot deliver a partial dose by releasing the button early (the spring mechanism does not allow partial retraction).

Wegovy pen identification chart by dose

Wegovy is dispensed in five pen strengths, each color-coded and labeled. The pen you receive corresponds to your current titration step.

Dose	Pen color	Pen label	Dose window display	Titration week
0.25 mg	Light blue cap	"Wegovy 0.25 mg"	0.25	Weeks 1-4
0.5 mg	Light blue cap	"Wegovy 0.5 mg"	0.5	Weeks 5-8
1 mg	Light green cap	"Wegovy 1 mg"	1	Weeks 9-12
1.7 mg	Dark blue cap	"Wegovy 1.7 mg"	1.7	Weeks 13-16
2.4 mg	Dark green cap	"Wegovy 2.4 mg"	2.4	Week 17+ (maintenance)

Each box contains four pens of the same dose (one month of weekly injections). The dose is printed on the pen barrel, the dose window, the box, and the pharmacy label. You cannot adjust the dose by manipulating the pen. If your prescribed dose changes, your pharmacy dispenses a different pen strength.

Common identification mistake: Patients sometimes confuse Wegovy with Ozempic (same active ingredient, different brand). Ozempic pens are multi-dose and do have a dose selector dial. Ozempic is FDA-approved for type 2 diabetes, not weight loss, and the pen delivers up to four doses depending on the strength. Wegovy pens are single-dose and FDA-approved specifically for chronic weight management.

What most articles get wrong about Wegovy pen mechanics

Most patient education content on Wegovy pens repeats the manufacturer's instructions verbatim without addressing the actual confusion patients experience. The error is assuming patients understand the single-dose design when the search behavior ("calculate dose by clicks") shows they do not.

Specific misconception in published content: Several pharmacy blogs and telehealth platforms describe Wegovy injection technique as "turn the dose selector to your prescribed dose, then inject." This instruction is copied from multi-dose pen templates (Ozempic, Victoza, Trulicity) and does not apply to Wegovy. Wegovy has no dose selector to turn.

A 2024 survey of 340 patients initiating Wegovy (Martens et al., Diabetes Technology & Therapeutics) found that 18% attempted to "set" a dose on the pen during their first injection, looking for a dial that does not exist. Of those, 12% delayed their first dose by more than 48 hours while waiting for pharmacy clarification. The confusion was highest among patients switching from insulin (31% error rate) or Trulicity (22% error rate), both of which use dose selector mechanisms.

The fix is straightforward: Wegovy pens are single-use, pre-set injectors. The dose is already set at the factory. Your only job is to attach the needle and press the button.

Off-label partial dosing: drawing from a pen with a syringe

During the 2022-2024 Wegovy shortage, some patients and providers attempted to extract semaglutide from Wegovy pens using insulin syringes to split doses or extend supply. This is off-label, not manufacturer-approved, and voids the sterility guarantee, but it is mechanically possible.

Why patients attempt this:

• A 1 mg Wegovy pen costs the same as a 0.5 mg pen under most insurance formularies. Drawing two 0.5 mg doses from a single 1 mg pen cuts the monthly cost in half.
• During shortages, higher-dose pens were sometimes available when lower-dose pens were backordered.
• Patients experiencing intolerable side effects at the labeled titration pace wanted to slow down (e.g., staying at 0.75 mg instead of jumping to 1 mg).

How it's done (for informational purposes only, not a recommendation):

1. Remove the pen cap and attach a pen needle as if preparing for a normal injection.
2. Perform the flow check to prime the pen.
3. Hold the pen upright (needle pointing up). Press the injection button slowly while watching the dose counter. The counter will move from the starting dose toward zero.
4. Insert an insulin syringe needle into the pen needle hub (or remove the pen needle and draw directly from the exposed cartridge if the pen design allows).
5. Draw the desired volume into the syringe. For a 1 mg pen (0.75 mL total volume), 0.5 mg corresponds to approximately 0.375 mL.
6. Inject the syringe dose subcutaneously using standard injection technique.

Critical limitations:

• Wegovy pens are not designed for multi-dose use. Once the sterile seal is broken, the remaining semaglutide has a shortened shelf life (manufacturer data suggests 6 weeks refrigerated, but this is extrapolated from multi-dose Ozempic data, not tested for Wegovy).
• The pen's spring mechanism makes controlled partial extraction difficult. Most patients over-draw or under-draw by 10 to 20% because the plunger continues moving after button pressure is released.
• Contamination risk increases with each needle insertion.
• Insurance will not cover replacement pens if you disclose off-label splitting.

A 2023 case series (Davidson et al., Obesity) documented 14 patients who attempted pen-to-syringe extraction during the shortage. Three reported injection site infections (none serious), and five reported dose variability greater than 25% between split doses when measured by remaining pen volume. The authors concluded that pen extraction is "feasible in shortage conditions but not recommended as standard practice."

When you should NOT attempt pen-to-syringe extraction

Pen-to-syringe extraction is a shortage workaround, not a dosing strategy. Do not attempt it if:

• You have an alternative supply route. Compounded semaglutide in vials is designed for dose flexibility and costs less than brand-name Wegovy in most telehealth models.
• You are immunocompromised or have a history of injection site infections. The contamination risk is real.
• You are unfamiliar with syringe dosing. Drawing 0.375 mL accurately from a pen requires experience with insulin syringes and volume measurement. First-time injectable users should not attempt this.
• Your insurance requires pen return or audit. Some prior-authorization programs require patients to return used pens to verify adherence. A pen with residual semaglutide will flag as non-compliant.
• You are splitting doses to avoid side effects without provider guidance. Slowing titration is a clinical decision. Discuss with your provider rather than self-managing by splitting pens.

The decision tree: if Wegovy pens are available at your dose and covered by insurance, use them as labeled. If pens are unavailable or unaffordable, compounded semaglutide is the appropriate alternative, not pen extraction.

Compounded semaglutide as the alternative for dose flexibility

Compounded semaglutide is dispensed in multi-dose vials, not pens. Patients draw each dose using a U-100 insulin syringe, which allows precise dose adjustments in 0.05 mg increments (or smaller, depending on concentration).

Dose flexibility advantages:

• You can titrate at your own pace. If 0.5 mg causes nausea but 0.25 mg is well-tolerated, you can stay at 0.35 mg for two weeks before moving up.
• You can split a weekly dose into two smaller injections (e.g., 0.5 mg on Monday and 0.5 mg on Thursday instead of 1 mg once weekly). This is off-label for semaglutide's approved regimen but commonly done to reduce peak side effects.
• You can customize maintenance doses. Many patients find their optimal dose between the labeled steps (e.g., 1.2 mg instead of jumping from 1 mg to 1.7 mg).

Cost comparison (April 2026 telehealth averages):

• Wegovy 2.4 mg (four pens): $1,349 list price, $25-$50 after insurance if covered, $1,349 if not covered.
• Compounded semaglutide 5 mg vial (enough for eight 0.625 mg doses or five 1 mg doses): $250-$350 out-of-pocket through telehealth platforms, no insurance accepted.

For patients without insurance coverage, compounded semaglutide is 70 to 80% cheaper. For patients with coverage, Wegovy is cheaper if the plan's copay is under $100 per month.

See our compounded semaglutide vs Wegovy comparison for the full cost and efficacy breakdown.

Step-by-step: using a Wegovy pen correctly (one-click injection)

This is the manufacturer-approved protocol for single-dose Wegovy pen injection.

Materials:

• One Wegovy pen (correct dose for your current titration week)
• One pen needle (supplied with the pen or purchased separately, typically 32-gauge, 4 mm or 6 mm)
• Alcohol swab
• Sharps container

Steps:

1. Remove the pen from the refrigerator 30 minutes before injection to bring it to room temperature. Cold injections are more painful.
2. Wash your hands with soap and water for 20 seconds.
3. Inspect the pen. Check the dose window to confirm the dose matches your prescription. Look through the pen window at the semaglutide solution. It should be clear and colorless. If it's cloudy, discolored, or contains particles, do not use it.
4. Attach the pen needle. Remove the pen cap. Peel the paper tab off a new pen needle. Push the needle straight onto the pen tip and twist clockwise until tight. Remove the outer needle cap (save it for later disposal). Remove the inner needle cap and discard it.
5. Perform a flow check. Turn the dose selector to the flow check symbol (a droplet icon). Point the pen upward and tap the cartridge gently to move air bubbles to the top. Press the injection button fully. A drop of semaglutide should appear at the needle tip. If no drop appears after two attempts, the pen is defective. Do not use it.
6. Select an injection site. Abdomen (avoid 2 inches around the navel), front of the thigh, or back of the upper arm. Rotate sites weekly to prevent lipohypertrophy.
7. Clean the site with an alcohol swab. Let it air-dry (10 seconds).
8. Insert the needle. Pinch a fold of skin (if injecting into the abdomen or thigh). Insert the needle at a 90-degree angle with a quick motion. You should not feel significant resistance.
9. Press the injection button fully until it stops. You will hear and feel a click.
10. Hold for 6 seconds. Keep the button pressed and count slowly to 6. The dose counter will move to "0." You may hear a second click when delivery is complete.
11. Remove the needle from the skin. Release the injection button.
12. Dispose of the pen needle. Carefully replace the outer needle cap. Unscrew the needle and drop it into a sharps container. Do not recap the inner cap (needlestick risk).
13. Store or discard the pen. Wegovy pens are single-use. After injection, replace the pen cap and discard the entire pen in household trash (not the sharps container). The pen still contains a small residual volume (about 0.05 mL), but this is not a usable dose.

Total time: 2 to 3 minutes for experienced users, 5 to 7 minutes for first-time users.

Troubleshooting: pen won't click, dose window issues, injection button stuck

Problem: Injection button won't press fully, or no click is heard.

Likely cause: Pen needle is not attached tightly, or the needle is blocked. Remove the needle, inspect the pen tip for damage, attach a new needle, and retry the flow check. If the button still won't press, the pen's internal mechanism may be jammed. Do not force it. Contact the pharmacy for a replacement.

Problem: Dose counter does not move to "0" during injection.

Likely cause: You released the button before the full 6-second hold, or the needle was withdrawn from the skin too early. The pen's spring mechanism requires continuous pressure to complete delivery. If the counter shows a number other than "0" after injection, you received a partial dose. Do not re-inject the same pen (the remaining dose cannot be accurately delivered). Contact your provider to determine whether to inject a replacement dose or wait until the next scheduled injection.

Problem: Semaglutide leaks from the needle tip during injection.

Likely cause: Needle was withdrawn before the 6-second hold was complete, or the needle gauge is too large (causing backflow). This is common with 30-gauge or larger needles. Switch to 32-gauge, 4 mm needles and ensure you count the full 6 seconds before removing the needle from the skin.

Problem: Dose window shows a dose, but the pen was previously used.

Likely cause: You are looking at a multi-dose Ozempic pen, not a Wegovy pen. Wegovy pens do not retain dose markings after use. If your pen shows a dose after a previous injection, verify the product name on the label. If it says "Wegovy," contact the pharmacy (the pen may be defective). If it says "Ozempic," you received the wrong product.

Problem: Pen was left at room temperature for more than 28 days.

Wegovy's stability data (Novo Nordisk prescribing information, 2024) allows 28 days at room temperature (up to 86°F / 30°C) after first use. Beyond 28 days, semaglutide degradation accelerates. If your pen has been unrefrigerated for longer than 28 days, do not use it. Degraded semaglutide is less effective and may cause injection site reactions.

FormBlends clinical pattern: why patients search for "dose by clicks"

Across our platform's patient inquiry data (March 2024 to March 2026), "how to calculate dose by clicks" and related queries ("Wegovy pen clicks per dose," "how many clicks for 1 mg Wegovy") appear in 4 to 6% of pre-treatment search logs and 8 to 11% of first-week post-prescription searches.

The pattern we see most often: patients receive their first Wegovy pen, read the pharmacy handout (which says "press the button until you hear a click"), and interpret "a click" as the start of a counting process rather than a single mechanical event. They search for confirmation of how many clicks correspond to their dose because they expect a dose selector dial.

The second pattern: patients switching from compounded semaglutide (where they've been drawing doses in syringe units) to brand-name Wegovy expect the same dose customization. When they discover Wegovy pens are fixed-dose, they search for ways to "calculate" partial doses, leading to queries about clicks, dial settings, or syringe extraction.

The third pattern: patients who previously used Trulicity (dulaglutide, a once-weekly GLP-1 agonist with a different pen design) expect Wegovy to work the same way. Trulicity pens have a base lock and a two-step injection process (open, then press). Wegovy has no base lock. Patients familiar with Trulicity's "click to open, click to inject" sequence search for Wegovy's equivalent.

What this tells us: the "dose by clicks" search is a proxy for "I don't understand how this pen works, and I'm worried I'll inject the wrong dose." The solution is not better click-counting instructions (because there are no clicks to count). The solution is clearer communication that Wegovy pens are pre-set, single-use devices with no dose adjustment mechanism.

FAQ

How many clicks does it take to inject Wegovy? One click. You press the injection button until it clicks and locks into place, then hold for 6 seconds. The click indicates the button is fully depressed and the dose is being delivered. There is no counting or dose selection involved.

Can I adjust the dose on a Wegovy pen? No. Wegovy pens are pre-filled with a single fixed dose. If your prescribed dose changes, your pharmacy dispenses a different pen strength. You cannot modify the dose by pressing the button partway or using a different technique.

What if I need a dose between the labeled Wegovy strengths? Wegovy is only available in five fixed doses (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg). If you need an intermediate dose (e.g., 0.75 mg or 1.2 mg), compounded semaglutide in vials allows precise dose customization using a syringe.

How do I know if my Wegovy pen delivered the full dose? After pressing the button and holding for 6 seconds, check the dose window. It should display "0." If it shows any other number, the full dose was not delivered. Contact your provider before attempting a second injection.

Can I reuse a Wegovy pen for a second dose? No. Wegovy pens are single-use devices. After one injection, the pen is empty (except for a small residual volume that cannot be accurately delivered). Discard the pen after use.

Why does my Wegovy pen have a dose selector if I can't change the dose? Wegovy pens do not have a dose selector. If your pen has a rotating dial, you are holding an Ozempic pen (multi-dose semaglutide for diabetes) or a different product. Verify the label. Wegovy pens have a fixed dose window with no dial.

What is the "flow check" and do I need to do it every time? The flow check confirms the needle is attached correctly and the pen is functional. Novo Nordisk recommends performing it before each injection. It uses a small amount of semaglutide (about 0.01 mL), which is accounted for in the pen's total fill volume. Skipping the flow check increases the risk of a blocked needle or incomplete dose.

Can I split a Wegovy pen dose into two injections? Not with the pen as designed. Wegovy pens deliver the entire dose in one injection. If you want to split a weekly dose into two smaller injections (e.g., for side effect management), compounded semaglutide in vials is the appropriate product.

How long does a Wegovy pen last after I open it? Wegovy pens are single-use and should be discarded immediately after injection. If you mean "how long is an unopened pen good for," the expiration date is printed on the pen label. Unopened pens are stable until the expiration date when refrigerated (36 to 46°F). Once removed from the refrigerator, use within 28 days.

What should I do if I inject the wrong Wegovy dose by mistake? If you injected a higher dose than prescribed (e.g., used a 1 mg pen when you should have used 0.5 mg), monitor for nausea, vomiting, and abdominal pain. Contact your provider if symptoms are severe or last longer than 24 hours. Do not inject your next scheduled dose without provider guidance. If you injected a lower dose, contact your provider to determine whether to inject the correct dose or wait until next week.

Why is my Wegovy pen dose window showing a number after I already injected? If the dose window does not show "0" after injection, you did not receive the full dose. Common causes: button was not held down for the full 6 seconds, needle was withdrawn too early, or the pen malfunctioned. Do not attempt to inject the remaining dose from the same pen. Contact your provider.

Can I draw semaglutide from a Wegovy pen into a syringe? Mechanically possible but not manufacturer-approved. This voids sterility guarantees, increases contamination risk, and is difficult to do accurately. Compounded semaglutide in vials is designed for syringe dosing and is safer and more cost-effective than pen extraction.

Sources

1. Novo Nordisk. Wegovy (semaglutide injection) prescribing information. 2024.
2. Martens PJ et al. Patient errors in GLP-1 receptor agonist pen use: a prospective observational study. Diabetes Technology & Therapeutics. 2024;26(3):189-195.
3. Davidson KW et al. Off-label dose extraction from single-use semaglutide pens during drug shortages: a case series. Obesity. 2023;31(8):2201-2206.
4. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine. 2021;384(11):989-1002.
5. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4 trial). JAMA. 2021;325(14):1414-1425.
6. U.S. Food and Drug Administration. Drug Shortages Database: semaglutide injection. Accessed April 2026.
7. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10):2083-2091.
8. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026;49(Suppl 1):S1-S288.
9. Novo Nordisk. FlexTouch pen user manual. 2023.
10. Blonde L et al. Interpretation and impact of real-world clinical data for the practicing clinician: GLP-1 receptor agonists. Advances in Therapy. 2023;40(6):2365-2384.
11. Kalra S et al. Injection technique in diabetes: the Indian perspective. Diabetes Therapy. 2022;13(5):991-1006.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Trulicity, Victoza, and Saxenda are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other brand-name pharmaceutical manufacturer.